We wish to inform to the Exchange that Trident Lifeline Limited has made further Investment by acquiring an additional equity stake of 1.00% of TRIDENT MEDIQUIP LIMITED (TML) (CIN: U33309GJ2019PLC110421), a subsidiary company from existing shareholders of the Company. Pursuant to the above, the shareholding of the company in Trident Mediquip Limited has increased from 58.67 % to 59.67%.

Date: 30.09.2026 BSE Limited Stock ID: TLL P. J. Towers, Scrip Code: 543616 Dalal Street, Fort, ISIN: INE0MKA01014 Mumbai – 400001. Dear Sir/Ma’am, Sub: Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/Ma’am, We wish to inform to the Exchange that Trident Lifeline Limited has made further Investment by acquiring an additional equity stake of 1.00% of TRIDENT MEDIQUIP LIMITED (TML) (CIN: U33309GJ2019PLC110421), a subsidiary company from existing shareholders of the Company. Pursuant to the above, the shareholding of the company in Trident Mediquip Limited has increased from 58.67 % to 59.67%. We enclosed herewith the details required under Regulation 30 of SEBI (LODR) Regulations, 2015 and SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 as Annexure – A. Thanking You. Yours faithfully, FOR TRIDENT LIFELINE LIMITED NIKITA SHARMA COMPANY SECRETARY AND COMPLIANCE OFFICER M. NO.: A60595 Registered Office: 2004, 2nd Floor, North Extension, Falsawadi, Ring Road, Surat-395003, Gujarat, INDIA. Tel : +91 261 2451274, 2451284 Email : info@tridentlifeline.com Web : www.tridentlifeline.com Factory Address: Plot No. 4240, Road No. 42, Sachin GIDC, Surat, Gujarat - 394230, India. Annexure-A Information under Regulation 30 of SEBI (LODR) Regulations, 2015 and SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 Sr. Particulars Details 1 Name of the target entity, TRIDENT MEDIQUIP LIMITED (CIN: details in brief such as size, U33309GJ2019PLC110421) Company incorporated turnover etc. under the provisions of the Companies Act, 2013, having its Registered Office in Surat, Gujarat Capital Details: Authorized Share Capital: Rs. 11,00,00,000/- divided into 1,10,00,000 Equity Shares of Rs.10/- each Paid-up Share Capital: Rs. 10,00,00,000/- divided into 1,00,00,000 Equity Shares of Rs.10/- each Turnover: 27.31 Cr 2 Whether the acquisition would Yes, TRIDENT MEDIQUIP LIMITED, Subsidiary of fall within related party Trident Lifeline Limited, therefore is a related transaction(s) and whether the party. Also Mr. Amit Bhupendra Halvawala and Mr. promoter/ promoter group/ Chetan Chandrakant Jariwala (director’s Relative of group companies have any Rupaben Jariwala) are member cum Director, Mr. interest in the entity being Hardik Jigishkumar Desai members and all of above acquired? If yes, nature of are part of promoters/promoter group/board of interest and details thereof and acquiring Company i.e being Trident Lifeline whether the same is done at Limited (The Company), have an interest in the “arm’s length” entity being acquired (TML). The transaction is being undertaken on an arm's length basis. 3 Industry to which the entity Medical Device Industry being acquired belongs 4 Objects and impact of TRIDENT MEDIQUIP LIMITED is a subsidiary of the acquisition (including but not company. In order to further increase its stake in limited to, disclosure of reasons TML, the percentage of holding its stake in TML for acquisition of target entity, if stands at 59.67%. its business is outside the main line of business of the listed entity) Registered Office: 2004, 2nd Floor, North Extension, Falsawadi, Ring Road, Surat-395003, Gujarat, INDIA. Tel : +91 261 2451274, 2451284 Email : info@tridentlifeline.com Web : www.tridentlifeline.com Factory Address: Plot No. 4240, Road No. 42, Sachin GIDC, Surat, Gujarat - 394230, India. 5 Brief details of any NA governmental or regulatory approvals required for the acquisition. 6 Indicative time period for NA completion of the acquisition 7 Consideration - whether cash Cash consideration consideration or share swap and details of the same; 8 Cost of acquisition or the price Cost of acquisition is approx. 95.40 lacs. at which the shares are acquired; 9 Percentage of shareholding / Pre-acquisition holding: 58.67 % control acquired and / or number of shares acquired; Post-acquisition holding: 59.67 % 10 Brief background about the Date of incorporation: October 19, 2019 entity acquired in terms of products/line of business Product/line of business: Medical Device Industry acquired, date of incorporation, history of last 3 years turnover, Last 3 years' turnover: country in which the acquired Financial year 2023-24- 20.58 Cr. entity has presence and any Financial Year 2024-25- 21.29 Cr. other significant information (in Financial Year 2025-26- 27.31 Cr. brief); Presence of entity: India Registered Office: 2004, 2nd Floor, North Extension, Falsawadi, Ring Road, Surat-395003, Gujarat, INDIA. Tel : +91 261 2451274, 2451284 Email : info@tridentlifeline.com Web : www.tridentlifeline.com Factory Address: Plot No. 4240, Road No. 42, Sachin GIDC, Surat, Gujarat - 394230, India.